Gain Therapeutics Inc. (GANX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Marshall Wace LLP

Paul Marshall And Ian Wace

1,662,293 $5,352,582 +850% 0%
2.
Potomac Capital Management

Paul Solit And Eric Singer

1,010,000 $3,252,200 2.61%
3.
Greenlight Capital

David Einhorn

566,130 $1,822,939 0.06%
4. 51,400 $165,508 +400% 0%
5.
Springbok Capital

Gavin Saitowitz And Cisco J. Del Valle

35,820 $115,340 0.01%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$1.01 14,400 $14,544.00 14,400 2024-08-09 Filing
$1.00 50,000 $49,940.00 50,000 2024-08-09 Filing
$1.21 12,000 $14,520.00 289,629 2024-07-01 Filing
$1.23 5,000 $6,150.00 277,629 2024-07-01 Filing
$3.86 30,000 $115,770.00 30,000 2024-03-28 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$2.46 206 $506.76 5,286 2023-12-21 Filing
$2.50 1,820 $4,550.00 4,855 2023-12-07 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 702,213 $2,261,126 0%
2. 684,349 $2,203,604 0%
3. 569,901 $1,835,082 0%
4. 397,942 $1,282,455 0%
5. 242,328 $780,296 0%
News See All